Winslow Asset Management Inc Eli Lilly & CO Transaction History

Winslow Asset Management Inc

$541 Million
Q3 2024

A detailed history of Winslow Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Winslow Asset Management Inc holds 34,043 shares of LLY stock, worth $26.9 Million. This represents 5.58% of its overall portfolio holdings.

Number of Shares

34,043

Previous 34,656 1.77%

Holding current value

$26.9 Million

Previous $31.4 Million 3.88%

% of portfolio

5.58%

Previous 6.18%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$772.14 - $960.02 $473,321 - $588,492	-613 Reduced 1.77%	34,043 $30.2 Million
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $1.31 Million - $1.64 Million	-1,802 Reduced 4.94%	34,656 $31.4 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $618,849 - $827,932	-1,045 Reduced 2.79%	36,458 $28.4 Million
Q4 2023 Feb 16, 2024	SELL	$525.19 - $619.13 $211,126 - $248,890	-402 Reduced 1.06%	37,503 $21.9 Million
Q3 2023 Nov 07, 2023	SELL	$434.7 - $599.3 $1.15 Million - $1.58 Million	-2,636 Reduced 6.5%	37,905 $20.4 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $208,339 - $278,574	-594 Reduced 1.44%	40,541 $19 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $195,386 - $229,471	-629 Reduced 1.51%	41,135 $14.1 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $872,686 - $1.02 Million	-2,714 Reduced 6.1%	41,764 $15.3 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $598,889 - $682,497	-2,020 Reduced 4.34%	44,478 $14.4 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $15,608 - $18,327	-56 Reduced 0.12%	46,498 $15.1 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $179,303 - $222,828	-764 Reduced 1.61%	46,554 $13.3 Million
Q4 2021 Feb 07, 2022	BUY	$224.85 - $279.04 $24,958 - $30,973	111 Added 0.24%	47,318 $13.1 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $165,092 - $203,168	-745 Reduced 1.55%	47,207 $10.9 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $228,395 - $295,428	-1,265 Reduced 2.57%	47,952 $11 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $358,217 - $463,729	-2,180 Reduced 4.24%	49,217 $9.2 Million
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $73,970 - $97,881	-567 Reduced 1.09%	51,397 $8.68 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $258,809 - $299,360	-1,770 Reduced 3.29%	51,964 $7.69 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $118,412 - $142,508	-868 Reduced 1.59%	53,734 $8.82 Million
Q1 2020 May 12, 2020	SELL	$119.05 - $147.35 $294,886 - $364,985	-2,477 Reduced 4.34%	54,602 $7.57 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $172,248 - $213,344	1,611 Added 2.9%	57,079 $7.5 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $716,988 - $779,898	-6,714 Reduced 10.8%	55,468 $6.2 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $470,857 - $549,610	-4,250 Reduced 6.4%	62,182 $6.89 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $76,469 - $90,010	-687 Reduced 1.02%	66,432 $8.62 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $22,556 - $25,270	-213 Reduced 0.32%	67,119 $7.77 Million
Q3 2018 Oct 18, 2018	SELL	$85.86 - $107.31 $30,051 - $37,558	-350 Reduced 0.52%	67,332 $7.23 Million
Q2 2018 Jul 13, 2018	BUY	$75.7 - $86.88 $20,439 - $23,457	270 Added 0.4%	67,682 $5.78 Million
Q1 2018 Apr 26, 2018	BUY	$74.21 - $87.6 $6,901 - $8,146	93 Added 0.14%	67,412 $5.22 Million
Q4 2017 Jan 11, 2018	BUY	$81.94 - $87.89 $29,088 - $31,200	355 Added 0.53%	67,319 $5.69 Million
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $5.16 Million - $5.73 Million	66,964	66,964 $5.73 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winslow Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Winslow Asset Management Inc with notifications on news.

Account

Winslow Asset Management Inc Eli Lilly & CO Transaction History